Antibody Discovery Market Growth Trajectory Through 2024-2033

The Antibody Discovery Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Antibody Discovery Market:
https://www.thebusinessresearchcompany.com/report/antibody-discovery-global-market-report

According to The Business Research Company’s Antibody Discovery Global Market Report 2024, The antibody discovery market size is expected to see rapid growth in the next few years. It will grow to $13.21 billion in 2028 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to increasing demand for antibody drug discovery services and platforms, surge in funding for the development of novel technologies, growing demand for precision therapeutics, and broadening the utilization of antibodies beyond their conventional therapeutic roles. Major trends in the forecast period include increased research and development activities, growing demand for monoclonal antibodies, increased adoption of advanced technologies, growing demand for targeted therapeutics, and development of novel antibody formats.

The growing need for precision therapeutics is expected to propel the growth of the antibody discovery market going forward. Precision therapeutics, also known as personalized therapeutics, refers to the customization of medical treatment plans and interventions to the individual characteristics of each patient. Antibody discovery is used in precision therapeutics, enabling the development of targeted therapies, such as monoclonal antibodies, designed to interact with disease-related molecules or cells specifically and precisely for more effective and personalized treatment. For instance, in January 2023, according to the Personalized Medicine Coalition, a US-based professional membership organization, the Food and Drug Administration’s Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs) in 2022 and out of the 35 therapeutic NMEs, approximately 34%, which amounts to 12 of them, are classified as personalized medicines by the Personalized Medicine Coalition (PMC). Therefore, the growing need for precision therapeutics will drive the growth of the antibody discovery market.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=13783&type=smp

The antibody discovery market covered in this report is segmented –

1) By Methods: Phage Display, Hybridoma, Other Methods
2) By Antibody Type: Humanized Antibody, Human Antibody, Chimeric Antibody, Murine Antibody
3) By End Users: Pharmaceutical And Biotechnology Industry, Research Laboratory, Academic Laboratory

Major companies operating in the antibody discovery market are developing innovative technologies, such as an AI-based computational antibody drug discovery platform, to improve the efficiency and precision of antibody development. An AI-based computational antibody drug discovery platform utilizes artificial intelligence and computational techniques to expedite the identification and optimization of therapeutic antibodies. For instance, in October 2023, SwiftPharma BV, a Belgium-based company developing recombinant proteins from a specialized plant-based system, introduced an AI-driven antibody discovery platform. This innovative tool combines artificial intelligence, big data, machine learning, and phage display techniques to rapidly predict high-specificity and high-affinity antibody-antigen binding. This approach, akin to natural language processing, generates diverse antibody variations, enabling SwiftPharma to create comprehensive antibody libraries efficiently. This advanced system accelerates the discovery of potential antibody drugs with unprecedented speed.

The antibody discovery market report table of contents includes:

1. Executive Summary
2.Antibody Discovery  Market Characteristics
3.Antibody Discovery  Market Trends And Strategies
4.Antibody Discovery Market analysis
5.Antibody Discovery  Market Size And Growth
6.Antibody Discovery  Segmentation
7.Antibody Discovery  Regional And Country Analysis
.
.
.
27.Antibody Discovery  Competitive Landscape And Company Profiles
28.Antibody Discovery  Key Mergers And Acquisitions
29.Antibody Discovery  Future Outlook and Potential Analysis

TOP MAJOR PLAYERS:

• Danaher Corporation
• Eurofins Scientific
• Sartorius AG
• Charles River Laboratories
• Bruker Corporation
• WuXi Biologics

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model